Lactate dehydrogenase-release assay: A reliable, nonradioactive technique for analysis of cytotoxic lymphocyte-mediated lytic activity against blasts from acute myelocytic leukemia-Reference-Cited by-同舟云学术

Lactate dehydrogenase-release assay: A reliable, nonradioactive technique for analysis of cytotoxic lymphocyte-mediated lytic activity against blasts from acute myelocytic leukemia

Published:1995-03 Issue:3 Volume:70 Page:153-158
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Weidmann E.,Brieger J.,Jahn B.,Hoelzer D.,Bergmann L.,Mitrou P. S.

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF01682036.pdf

Reference18 articles.

1. Adler A, Chervenick PA, Whiteside TL, Lotzova E, Herberman RB (1988) Interleukin 2 induction of lymphokine-activated killer (LAK) activity in the peripheral blood and bone marrow of acute leukemia patients. I. Feasibility of LAK generation in adult patients with active disease in remission. Blood 71:709–716

2. Adler A, Albo V, Blatt J, Whiteside TL, Herberman RB (1989) Interleukin 2 induction of lymphokine-activated killer (LAK) activity in the peripheral blood and bone marrow of acute leukemia patients. II. Feasibility of LAK generation in children with active disease and in remission. Blood 74:1690–1697

3. Archimbaud E, Bailly M, Dore JF (1991) Inducibility of lymphokine-activated killer (LAK) cells in patients with acute myelogenous leukemia in complete remission and its clinical relevance. Br J Heamatol 77:328–335

4. Bergmann L, Fenchel K, Weidmann E, Enzinger HM, Jahn B, Jonas D, Mitrou PS (1993) Daily alternating administration of high-dose alpha-2b-interferon and interleukin 2 bolus infusion in metastatic renal cell cancer. A phase-II study. Cancer 72:1733–1742

5. Bergmann L, Heil G, Kolbe K, Lengfelder E, Puzicha E, Martin H, J, Lohmeyer J, Mitrou PS, Hoelzer D (1994) Interleukin 2 bolus infusion as late consolidation therapy in 2nd remission of acute myelocytic leukemia. Leukemia Lymphoma (in press)

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cell Proliferation and Cytotoxicity Assays, The Fundamentals for Drug Discovery;International Journal of Drug Discovery and Pharmacology;2024-08-20

2. Deep Learning-Based Automated Analysis of NK Cell Cytotoxicity in Single Cancer Cell Arrays;BioChip Journal;2024-06-27

3. Diagnostic methods to assess the numbers, phenotype, and function of primary and engineered NK cells: Methods to predict prognosis and treatment outcome;NK Cells in Cancer Immunotherapy: Successes and Challenges;2023

4. Modular Synthetic Routes to Fluorine-Containing Halogenated Phenazine and Acridine Agents That Induce Rapid Iron Starvation in Methicillin-Resistant Staphylococcus aureus Biofilms;ACS Infectious Diseases;2022-01-28

5. Feline adipose-derived mesenchymal stem cells induce effector phenotype and enhance cytolytic function of CD8+ T cells;Stem Cell Research & Therapy;2021-09-06